本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Amphastar Pharmaceuticals

26.02
-0.0400-0.15%
盘后26.020.00000.00%16:10 EST
成交量:41.93万
成交额:1,092.87万
市值:11.96亿
市盈率:11.47
高:26.54
开:26.04
低:25.69
收:26.06
52周最高:46.43
52周最低:20.39
股本:4,595.22万
流通股本:3,480.31万
量比:0.74
换手率:1.20%
股息:- -
股息率:- -
每股收益(TTM):2.27
每股收益(LYR):3.29
净资产收益率:14.84%
总资产收益率:5.84%
市净率:1.54
市盈率(LYR):7.90

数据加载中...

2025/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/04

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

重要事件披露

Form 8-K - Current report
2024/12/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/06

重要事件披露

Form 8-K - Current report
2024/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/30

重要事件披露

Form 8-K - Current report
2024/08/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/07

重要事件披露

Form 8-K - Current report
2024/07/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities